2 completed, 2 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Terminated 2 |
Follow OM Pharma SA: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children With Recurrent Wheezing OM-85, Placebo - Recurrent Wheezing, Wheezing Lower Respiratory Illness | Phase 2 | Completed | OM Pharma SA | 296 | 2023-06-20 | 2026-10-16 |
| Assessment of the Efficacy of Calcium Dobesilate vs. Placebo on SARS-CoV-2 Viral Load Amongst Outpatients With COVID-19. Calcium Dobesilate, Mannitol - COVID-19 Virus Disease | Phase 2 | Completed | Hervé SPECHBACH | 74 | 2022-05-17 | 2024-02-28 |
| Immunomodulation by OM-85 (Broncho-Vaxom) in Early AD Broncho-Vaxom, Placebo - Atopic Dermatitis | Phase 2 | Terminated | OM Pharma SA | 63 | 2021-12-20 | 2023-08-08 |
| Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD) Azithromycin, Metronidazole, Standard of Care - Crohn Disease, Pediatric Crohns Disease | Phase 2 | Terminated | University of North Carolina, Chapel Hill | 13 | 2021-08-13 | 2025-06-29 |
COVID-19 (1) · Crohn Disease (1) · Dermatitis, Atopic (1) · Lymphoma, Follicular (1) · Respiratory Sounds (1)
Azithromycin (1) · Broncho-Vaxom (1) · Calcium Dobesilate (1) · Mannitol (1) · Metronidazole (1) · Standard of Care (1)
Netherlands (2) · Poland (2) · United States (2) · Australia (1) · Canada (1) · France (1) · Germany (1) · Hungary (1) · Israel (1) · Switzerland (1)
Arie Levine, MD (1) · Francisco Sylvester, MD (1) · Franziska Rueff, Professor (1) · Johan E Van Limbergen, MD, PhD (1)